Introduction
Safe blood transfusion is the term refers to judicial and rational therapeutic use of blood and blood products. World Healh Organization (WHO) recommendation of safe blood transfusion is provision of compatible blood which are cross matched and screened for at least five WHO recommended transfusion transmitted infection i.e. Human Immunodeficiency Virus (HIV), Hepatitis C virus (HCV), Hepatitis B Virus (HBV), Syphilis and Malarial parasite 1 .
The idea of blood transfusion appeared in the fifteenth and sixteenth centuries with the belief that transfusion of blood from a young and healthy person to an aged or debilitated individual would restore youth and health. With this idea in mind pope innocent VIII was given blood from three unfortunate persons in 1542 and all the four died. In ancient history people also drink blood to be enriched with supernatural power 2 In our country the annual demand for blood transfusion is estimated to be 2,00,000 to 2,50,000 unit per year . But due to lack of voluntary donor and consciousness among people this demand is hardly met 4 . South East Asia account for 25% of the worlds population but collects only 9% of the world's blood supply as a result 7 million units of blood in a year, but there is need of a total 15 million units of blood. In Bangladesh the prevalence of HIV now in general population is 0.1% except for injecting drug users. In 2006, 216 new cases of HIV were reported. By the end of 2004, 7,500 people were infected with HIV and between 2.2 and 3.9 million more people were in risk of acquiring HIV 5 .
Where as HCV became a serious problem according to study by Dhaka Shishu Hospital thalassaemia center where 19.4% multi transfused thalassaemia patients were anti HCV positive. Red crescent data of Bangladesh showed hepatitis B positive 0.2%, hepatitis C positive 0.3% and syphilis 0.5% in voluntary donors, while in professional donors hepatitis B was positive in 29%, hepatitis C in 6% and syphilis in 22%. So professional donors must be discouraged 6 .
In 2002 report received from safe blood transfusion centers showed that 52% donated blood comes from relatives, 28% from voluntary donors and 20% from professional blood donors 7 .
Donor selection is the most important part to avail safe donor by maintaining proper donor selection protocol of WHO and by ensuring or justifying proper deferral of inappropriate blood donor 8 . New modern technologies have been implemented in developed countries and emerging trends are autologous blood transfusion and preservation of rare blood group, peripheral stem cell transplantation (PBST), cord blood transplantation, gene therapy and cloned blood . In our country clinicians should be committed to provide judicial and appropriate usage of blood and blood products. Modern technology like gel document/micro typing (column agglutination technology), component separation by buffy coat method (refrigerated centrifuge technique), platelet aphaeresis, plasma aphaeresis and therapeutic aphaeresis are in lime-light in our country. Full filling the criteria for proper donor selection and by implementation of WHO protocol and national rule of transfusion services and blood banking safe blood transfusion programme trying to reach to its goal . Advanced skill in serological technique, provision of risk free blood component, proper therapeutic process, logical and judicial use of blood, provision of out patient treatment and day care services are current trend to provide appropriate care for the patients having blood diseases .
Transfusion of blood from first degree relatives are not free of risk also, worse out come in marrow transplantation with development of anti-body are important issue in relative/party blood donation . As no blood is safe due to window period of HIV,HCV& HBV viruses and hazard is more in whole blood transfusion appropriate clinical use of blood is mandatory 6 .
Safe blood transfusion programme is increasing its field by availing these strategies. So we can hope in near feature that safe blood transfusion can also remove anxiety from patients having genetical blood diseases with counselling, stem cell transplantation (SCT) and gene therapy. 
